204 related articles for article (PubMed ID: 23172727)
1. Tissue-specific responses to aberrant FGF signaling in complex head phenotypes.
Martínez-Abadías N; Motch SM; Pankratz TL; Wang Y; Aldridge K; Jabs EW; Richtsmeier JT
Dev Dyn; 2013 Jan; 242(1):80-94. PubMed ID: 23172727
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of
Lee KKL; Peskett E; Quinn CM; Aiello R; Adeeva L; Moulding DA; Stanier P; Pauws E
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266836
[TBL] [Abstract][Full Text] [Related]
3. Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.
Liu J; Nam HK; Wang E; Hatch NE
Calcif Tissue Int; 2013 May; 92(5):451-66. PubMed ID: 23358860
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
Eswarakumar VP; Ozcan F; Lew ED; Bae JH; Tomé F; Booth CJ; Adams DJ; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18603-8. PubMed ID: 17132737
[TBL] [Abstract][Full Text] [Related]
5. The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT.
Perlyn CA; DeLeon VB; Babbs C; Govier D; Burell L; Darvann T; Kreiborg S; Morriss-Kay G
Cleft Palate Craniofac J; 2006 Nov; 43(6):740-8. PubMed ID: 17105336
[TBL] [Abstract][Full Text] [Related]
6. A dysmorphic mouse model reveals developmental interactions of chondrocranium and dermatocranium.
Motch Perrine SM; Pitirri MK; Durham EL; Kawasaki M; Zheng H; Chen DZ; Kawasaki K; Richtsmeier JT
Elife; 2022 Jun; 11():. PubMed ID: 35704354
[TBL] [Abstract][Full Text] [Related]
7. FGFR2c-mediated ERK-MAPK activity regulates coronal suture development.
Pfaff MJ; Xue K; Li L; Horowitz MC; Steinbacher DM; Eswarakumar JVP
Dev Biol; 2016 Jul; 415(2):242-250. PubMed ID: 27034231
[TBL] [Abstract][Full Text] [Related]
8. Synchondrosis fusion contributes to the progression of postnatal craniofacial dysmorphology in syndromic craniosynostosis.
Hoshino Y; Takechi M; Moazen M; Steacy M; Koyabu D; Furutera T; Ninomiya Y; Nuri T; Pauws E; Iseki S
J Anat; 2023 Mar; 242(3):387-401. PubMed ID: 36394990
[TBL] [Abstract][Full Text] [Related]
9. Computational mouse atlases and their application to automatic assessment of craniofacial dysmorphology caused by the Crouzon mutation Fgfr2(C342Y).
Olafsdóttir H; Darvann TA; Hermann NV; Oubel E; Ersbøll BK; Frangi AF; Larsen P; Perlyn CA; Morriss-Kay GM; Kreiborg S
J Anat; 2007 Jul; 211(1):37-52. PubMed ID: 17553099
[TBL] [Abstract][Full Text] [Related]
10. Aberrant bony vasculature associated with activating fibroblast growth factor receptor mutations accompanying Crouzon syndrome.
Tholpady SS; Abdelaal MM; Dufresne CR; Gampper TJ; Lin KY; Jane JA; Morgan RF; Ogle RC
J Craniofac Surg; 2004 May; 15(3):431-5; discussion 436-8. PubMed ID: 15111803
[TBL] [Abstract][Full Text] [Related]
11. C-type natriuretic peptide analog treatment of craniosynostosis in a Crouzon syndrome mouse model.
Holmes G; Zhang L; Rivera J; Murphy R; Assouline C; Sullivan L; Oppeneer T; Jabs EW
PLoS One; 2018; 13(7):e0201492. PubMed ID: 30048539
[TBL] [Abstract][Full Text] [Related]
12. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis.
Eswarakumar VP; Horowitz MC; Locklin R; Morriss-Kay GM; Lonai P
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12555-60. PubMed ID: 15316116
[TBL] [Abstract][Full Text] [Related]
13. The effects of tissue-non-specific alkaline phosphatase gene therapy on craniosynostosis and craniofacial morphology in the FGFR2C342Y/+ mouse model of Crouzon craniosynostosis.
Wang E; Nam HK; Liu J; Hatch NE
Orthod Craniofac Res; 2015 Apr; 18 Suppl 1(0 1):196-206. PubMed ID: 25865549
[TBL] [Abstract][Full Text] [Related]
14. Integration of Brain and Skull in Prenatal Mouse Models of Apert and Crouzon Syndromes.
Motch Perrine SM; Stecko T; Neuberger T; Jabs EW; Ryan TM; Richtsmeier JT
Front Hum Neurosci; 2017; 11():369. PubMed ID: 28790902
[TBL] [Abstract][Full Text] [Related]
15. A model for the pharmacological treatment of crouzon syndrome.
Perlyn CA; Morriss-Kay G; Darvann T; Tenenbaum M; Ornitz DM
Neurosurgery; 2006 Jul; 59(1):210-5; discussion 210-5. PubMed ID: 16823318
[TBL] [Abstract][Full Text] [Related]
16. Meckel's Cartilage in Mandibular Development and Dysmorphogenesis.
Pitirri MK; Durham EL; Romano NA; Santos JI; Coupe AP; Zheng H; Chen DZ; Kawasaki K; Jabs EW; Richtsmeier JT; Wu M; Motch Perrine SM
Front Genet; 2022; 13():871927. PubMed ID: 35651944
[TBL] [Abstract][Full Text] [Related]
17. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
18. Genotype-Phenotype Correlation of Tracheal Cartilaginous Sleeves and Fgfr2 Mutations in Mice.
Lam AS; Liu CC; Deutsch GH; Rivera J; Perkins JA; Holmes G; Jabs EW; Cunningham ML; Dahl JP
Laryngoscope; 2021 Apr; 131(4):E1349-E1356. PubMed ID: 32886384
[TBL] [Abstract][Full Text] [Related]
19. The Fgfr2 W290R mouse model of Crouzon syndrome.
Gong SG
Childs Nerv Syst; 2012 Sep; 28(9):1495-503. PubMed ID: 22872266
[TBL] [Abstract][Full Text] [Related]
20. FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models.
Martínez-Abadías N; Heuzé Y; Wang Y; Jabs EW; Aldridge K; Richtsmeier JT
PLoS One; 2011; 6(10):e26425. PubMed ID: 22053191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
